Regardless of the etiology, surgery to remove the disease-causing tumor is considered the first-line treatment for CS and results in biochemical remission in 60-80% of patients with pituitary CS and virtually 100% of patients with unilateral ACTH-independent adrenal nodular disease (6–10). Here, POMC is linked to Cowden syndrome 1.